Robin Carhart-Harris
Cited by
Cited by
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
RL Carhart-Harris, M Bolstridge, J Rucker, CMJ Day, D Erritzoe, M Kaelen, ...
The Lancet Psychiatry 3 (7), 619-627, 2016
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
RL Carhart-Harris, D Erritzoe, T Williams, JM Stone, LJ Reed, A Colasanti, ...
Proceedings of the National Academy of Sciences 109 (6), 2138-2143, 2012
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
RL Carhart-Harris, R Leech, PJ Hellyer, M Shanahan, A Feilding, ...
Frontiers in human neuroscience 8, 20, 2014
Trial of psilocybin versus escitalopram for depression
R Carhart-Harris, B Giribaldi, R Watts, M Baker-Jones, A Murphy-Beiner, ...
New England Journal of Medicine 384 (15), 1402-1411, 2021
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
RL Carhart-Harris, M Bolstridge, CMJ Day, J Rucker, R Watts, DE Erritzoe, ...
Psychopharmacology 235, 399-408, 2018
Neural correlates of the LSD experience revealed by multimodal neuroimaging
RL Carhart-Harris, S Muthukumaraswamy, L Roseman, M Kaelen, ...
Proceedings of the National Academy of Sciences 113 (17), 4853-4858, 2016
REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics
RL Carhart-Harris, KJ Friston
Pharmacological reviews 71 (3), 316-344, 2019
The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas
RL Carhart-Harris, KJ Friston
Brain 133 (4), 1265-1283, 2010
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of psychopharmacology 31 (9), 1091-1120, 2017
Homological scaffolds of brain functional networks
G Petri, P Expert, F Turkheimer, R Carhart-Harris, D Nutt, PJ Hellyer, ...
Journal of The Royal Society Interface 11 (101), 20140873, 2014
Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression
L Roseman, DJ Nutt, RL Carhart-Harris
Frontiers in pharmacology 8, 974, 2018
The therapeutic potential of psychedelic drugs: past, present, and future
RL Carhart-Harris, GM Goodwin
Neuropsychopharmacology 42 (11), 2105-2113, 2017
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
RL Carhart-Harris, L Roseman, M Bolstridge, L Demetriou, JN Pannekoek, ...
Scientific reports 7 (1), 1-11, 2017
Psychedelics and the essential importance of context
RL Carhart-Harris, L Roseman, E Haijen, D Erritzoe, R Watts, I Branchi, ...
Journal of psychopharmacology 32 (7), 725-731, 2018
Patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression
R Watts, C Day, J Krzanowski, D Nutt, R Carhart-Harris
Journal of humanistic psychology 57 (5), 520-564, 2017
Increased global functional connectivity correlates with LSD-induced ego dissolution
E Tagliazucchi, L Roseman, M Kaelen, C Orban, SD Muthukumaraswamy, ...
Current biology 26 (8), 1043-1050, 2016
Broadband cortical desynchronization underlies the human psychedelic state
SD Muthukumaraswamy, RL Carhart-Harris, RJ Moran, MJ Brookes, ...
Journal of Neuroscience 33 (38), 15171-15183, 2013
Single-dose psilocybin for a treatment-resistant episode of major depression
GM Goodwin, ST Aaronson, O Alvarez, PC Arden, A Baker, JC Bennett, ...
New England Journal of Medicine 387 (18), 1637-1648, 2022
Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI)
MM Nour, L Evans, D Nutt, RL Carhart-Harris
Frontiers in human neuroscience 10, 269, 2016
The entropic brain-revisited
RL Carhart-Harris
Neuropharmacology 142, 167-178, 2018
The system can't perform the operation now. Try again later.
Articles 1–20